Repligen (RGEN) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Repligen Corp  (NASDAQ: RGEN)
 

Repligen Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Repligen's inventory turnover ratio, the ratio that measures Repligen's ability to manage its supply chain, sequentially decreased to 2.07 in the third quarter 2026, but it does not raise any concerns as Repligen continue to execute well, and the inventory turnover ratio remains above the average. Repligen's average inventory processing period in the Sep 30 2026 quarter, has increased to 176 days, from 175 days, in the Jun 30 2026 quarter.

Within Healthcare sector 194 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1042 in the second quarter 2026, to 1491.

RGEN Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Repligen Corp Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RGEN Inventory Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Inventory Growth 13.65 % 19.72 % 17.08 % 19.23 % -12.14 %
Y / Y Cost of Sales Growth 11.37 % 5.28 % 9.64 % -26.9 % 14.09 %
Inventory Turnover Ratio (TTM) 2.07 2.08 2.15 2.19 2.51
RGEN's Total Ranking # 1491 # 1042 # 1042 # 853 #
Average inventory processing period 176 175 170 167 145
Seq. Inventory Growth -2.36 % 4.1 % 5.16 % 6.32 % 2.86 %
Seq. Cost of Sales Growth 4.5 % 9.45 % -8.62 % 6.56 % -1.21 %




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 16
Healthcare Sector # 195
Overall Market # 1491

Inventory Turnover Ratio Statistics
High Average Low
2.54 2.04 1.37
(Mar 31 2013)   (Jun 30 2012)



RGEN Company Profile >> Back to RGEN Efficiency Comparisons >> Compare RGEN Inventory Turnover Ratio to its Competitors

Financial Statements
Repligen's Inventories $ 182 Millions Visit RGEN's Balance sheet
Repligen's Cost of Revenues TTM $ 372 Millions Visit RGEN's Income Statement
What are RGEN's Sales? Visit RGEN's Sales by Segment

Other Inventory Turnover Ratios
Repligen's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
RGEN's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for RGEN's Competitors
Inventory Turnover Ratio for RGEN's Suppliers
Inventory Turnover Ratio for RGEN's Customers

You may also want to know
RGEN's Sales Growth Rates RGEN's Pe Price to earnings ratio RGEN's Receivables Turnover Ratio RGEN's Stock Quote
RGEN's Net Income Growth Rates RGEN's Ps Price to Sales ratio RGEN's Sales per Employee RGEN's Asset Turnover Ratio
RGEN's Net Margin RGEN's Pb Price to Book ratio RGEN's Financial Strength Ratios RGEN's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Avantor Inc   5.48 $ 4,539.200  Millions$ 828  Millions
Tactile Systems Technology Inc   5.25 $ 82.718  Millions$ 16  Millions
Integer Holdings Corporation  4.98 $ 1,376.268  Millions$ 276  Millions
Ge Healthcare Technologies Inc   4.69 $ 11,372.000  Millions$ 2,425  Millions
West Pharmaceutical Services Inc   4.69 $ 2,120.200  Millions$ 452  Millions
Henry Schein Inc   4.63 $ 9,395.000  Millions$ 2,031  Millions
Cryoport inc   4.60 $ 102.157  Millions$ 22  Millions
Myomo Inc   4.58 $ 14.802  Millions$ 3  Millions
Idexx Laboratories Inc  4.52 $ 1,743.379  Millions$ 386  Millions
Autolus Therapeutics Plc  4.34 $ 88.293  Millions$ 20  Millions
Medinotec Inc   4.28 $ 5.143  Millions$ 1  Millions
Electromed Inc   4.18 $ 14.878  Millions$ 4  Millions
Intelligent Bio Solutions Inc   4.14 $ 2.206  Millions$ 1  Millions
3m Company  4.02 $ 15,267.000  Millions$ 3,801  Millions
Novocure Limited  3.98 $ 166.721  Millions$ 42  Millions
Sonoma Pharmaceuticals Inc   3.90 $ 14.275  Millions$ 4  Millions
Koru Medical Systems Inc   3.88 $ 16.831  Millions$ 4  Millions
Incyte Corporation  3.79 $ 439.399  Millions$ 116  Millions
Baxter International Inc   3.57 $ 8,117.000  Millions$ 2,277  Millions
Bausch Health Companies Inc   3.54 $ 4,518.000  Millions$ 1,276  Millions
Coherus Oncology inc   3.50 $ 16.193  Millions$ 5  Millions
Exelixis Inc   3.49 $ 93.324  Millions$ 27  Millions
Abbvie Inc   3.40 $ 17,346.000  Millions$ 5,108  Millions
Gilead Sciences Inc   3.30 $ 6,219.000  Millions$ 1,884  Millions
Iovance Biotherapeutics inc   3.21 $ 177.232  Millions$ 55  Millions
Teva Pharmaceutical Industries Limited  3.16 $ 8,011.000  Millions$ 2,537  Millions
Msa Safety Inc  3.00 $ 1,063.235  Millions$ 354  Millions
Mimedx Group Inc   2.98 $ 70.562  Millions$ 24  Millions
Abbott Laboratories  2.95 $ 20,765.000  Millions$ 7,032  Millions
Revvity Inc  2.93 $ 1,122.448  Millions$ 384  Millions

Date modified: 2026-10-31T17:28:06+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.